SCHEMBL30890807

SCHEMBL30890807

Cc1cnc2c(c1)NC(=O)[C@@]1(C[C@@H](C(N)=O)N(C(=O)[C@H](CC3CC3)N(C)C(=O)OC(C)(C)C)C1)O2

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890602 1.00 CNR2 (0.32) CNR2
SCHEMBL27244901 0.90 CNR2 (0.32) CNR2
SCHEMBL27244872 0.90 CNR2 (0.32) CNR2
SCHEMBL30890631 0.90 AAK1 (0.32) —
SCHEMBL30890705 0.90 AAK1 (0.32) —
SCHEMBL27244681 0.88 CNR2 (0.33) CNR2
SCHEMBL27244675 0.88 CNR2 (0.33) CNR2
SCHEMBL30890777 0.86 — —
SCHEMBL30992288 0.86 MAPT (0.33) —
SCHEMBL27245156 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback